Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This is a compassionate use protocol for patients with acute lymphoblastic leukemia (ALL) who
have developed hypersensitivity or intolerance to E. coli L-asparaginase and/or
PEG-L-asparaginase.